| Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source New England Journal of Medicine 378 (23), 2191-2201, 2018 | 1065 | 2018 |
| The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2 MV Huisman, KJ Rothman, M Paquette, C Teutsch, HC Diener, SJ Dubner, ... Journal of the American College of Cardiology 69 (7), 777-785, 2017 | 352 | 2017 |
| Embolic strokes of undetermined source in the Athens stroke registry: an outcome analysis G Ntaios, V Papavasileiou, H Milionis, K Makaritsis, A Vemmou, ... Stroke 46 (8), 2087-2093, 2015 | 308 | 2015 |
| Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: a systematic review and … G Ntaios, V Papavasileiou, K Makaritsis, K Vemmos, P Michel, GYH Lip Stroke 48 (9), 2494-2503, 2017 | 262 | 2017 |
| Concordance of Murine Quantitative Trait Loci for Salt-Induced Hypertension With Rat and Human Loci BP F Sugiyama, GA Churchill, DC Higgins, C Johns, KP Makaritsis, H Gavras Genomics 71 (1), 70-77, 2001 | 250 | 2001 |
| CHADS2, CHA2DS2-VASc, and long-term stroke outcome in patients without atrial fibrillation G Ntaios, GYH Lip, K Makaritsis, V Papavasileiou, A Vemmou, E Koroboki, ... Neurology 80 (11), 1009-1017, 2013 | 209 | 2013 |
| Leishmaniasis revisited: current aspects on epidemiology, diagnosis and treatment SP Georgiadou, KP Makaritsis, GN Dalekos Journal of Translational Internal Medicine 3 (2), 43-50, 2015 | 207 | 2015 |
| Adipokines as mediators of endothelial function and atherosclerosis G Ntaios, NK Gatselis, K Makaritsis, GN Dalekos Atherosclerosis 227 (2), 216-221, 2013 | 206 | 2013 |
| Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of … G Ntaios, V Papavasileiou, HC Diener, K Makaritsis, P Michel Stroke 43 (12), 3298-3304, 2012 | 196 | 2012 |
| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 195 | 2018 |
| Role of the α2B-Adrenergic Receptor in the Development of Salt-Induced Hypertension KP Makaritsis, DE Handy, C Johns, B Kobilka, I Gavras, H Gavras Hypertension 33 (1), 14-17, 1999 | 156 | 1999 |
| Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOAC s) Study M Paciaroni, G Agnelli, N Falocci, G Tsivgoulis, K Vadikolias, C Liantinioti, ... Journal of the American Heart Association 6 (12), e007034, 2017 | 153 | 2017 |
| Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: updated systematic review and meta-analysis G Ntaios, V Papavasileiou, D Sagris, K Makaritsis, K Vemmos, T Steiner, ... Stroke 49 (2), 412-418, 2018 | 141 | 2018 |
| Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: an updated systematic review … G Ntaios, V Papavasileiou, HC Diener, K Makaritsis, P Michel International Journal of Stroke 12 (6), 589-596, 2017 | 137 | 2017 |
| Prevalence and overlap of potential embolic sources in patients with embolic stroke of undetermined source G Ntaios, K Perlepe, D Lambrou, G Sirimarco, D Strambo, A Eskandari, ... Journal of the American Heart Association 8 (15), e012858, 2019 | 122 | 2019 |
| Spontaneous spondylodiscitis: presentation, risk factors, diagnosis, management, and outcome E Kapsalaki, N Gatselis, A Stefos, K Makaritsis, A Vassiou, I Fezoulidis, ... International Journal of Infectious Diseases 13 (5), 564-569, 2009 | 122 | 2009 |
| A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice Z Zhao, K Makaritsis, CE Francis, H Gavras, K Ravid Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1500 (3), 280-290, 2000 | 117 | 2000 |
| Causes and risk factors of cerebral ischemic events in patients with atrial fibrillation treated with non–vitamin K antagonist oral anticoagulants for stroke prevention M Paciaroni, G Agnelli, V Caso, G Silvestrelli, DJ Seiffge, S Engelter, ... Stroke, 2019 | 108 | 2019 |
| Risk stratification for recurrence and mortality in embolic stroke of undetermined source G Ntaios, K Vemmos, GYH Lip, E Koroboki, E Manios, A Vemmou, ... Stroke 47 (9), 2278-2285, 2016 | 99 | 2016 |
| Sympathoinhibitory Function of the α2A-Adrenergic Receptor Subtype KP Makaritsis, C Johns, I Gavras, JD Altman, DE Handy, MR Bresnahan, ... Hypertension 34 (3), 403-407, 1999 | 95 | 1999 |
